Oliver Zolk
Institute of Experimental and Clinical Pharmacology and Toxicology
University of Erlangen-Nuremberg
Erlangen
Germany
Name/email consistency: high
- Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser. Zolk, O., Solbach, T.F., König, J., Fromm, M.F. Drug Metab. Dispos. (2009)
- Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Zolk, O., Solbach, T.F., König, J., Fromm, M.F. Naunyn Schmiedebergs Arch. Pharmacol. (2009)
- Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Zolk, O., Engmann, S., Münzel, F., Krajcik, R. Am. J. Physiol. Endocrinol. Metab. (2005)
- Effects of chronic endothelin-1 stimulation on cardiac myocyte contractile function. Zolk, O., Münzel, F., Eschenhagen, T. Am. J. Physiol. Heart Circ. Physiol. (2004)
- Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase. Zolk, O., Marx, M., Jäckel, E., El-Armouche, A., Eschenhagen, T. Cardiovasc. Res. (2003)
- Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats. Zolk, O., Quattek, J., Seeland, U., El-Armouche, A., Eschenhagen, T., Böhm, M. Cardiovasc. Res. (2002)
- Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance. Zolk, O., Ng, L.L., O'Brien, R.J., Weyand, M., Eschenhagen, T. Circulation (2002)









